Pfizer, CDC Withheld Evidence of Myocarditis After COVID Shots, New Documents Reveal
- Pfizer, CDC Withheld Evidence of Myocarditis After COVID Shots, New Documents Reveal
by Michael Nevradakis, Ph.D., https://childrenshealthdefense.org/defender/
Pfizer and the Centers for Disease Control and Prevention (CDC) withheld evidence that COVID-19 vaccinations were causing myocarditis, according documents obtained by Children’s Health Defense via a Freedom of Information Act request to the CDC, and documents leaked this week to Project Veritas.
–
Pfizer and the Centers for Disease Control and Prevention (CDC) withheld evidence that COVID-19 vaccinations led to an increased risk of myocarditis, especially in young males, according to two sets of documents made public this week.
–
Confidential Pfizer documents leaked Thursday by Project Veritas show the company had “evidence that suggests patients who receive a COVID-19 vaccine are at an increased risk of myocarditis.”
–
And heavily redacted CDC documents obtained by Children’s Health Defense (CHD) via a Freedom of Information Act (FOIA) request indicate the agency provided an undercounted figure of post-COVID-19-vaccination myocarditis cases to Israel’s Ministry of Health in early 2021.
–
The latest revelations come as Germany, Japan and other governments are raising questions about the significant numbers of severe adverse events recorded in individuals following administration of the COVID-19 vaccines.
–
According to researchers at the National Organization for Rare Disorders, myocarditis can result from infections, or it may result directly from a toxic effect such as a toxin or a virus. “More commonly the myocarditis is a result of the body’s immune reaction to the initial heart damage,” researchers said. Severe myocarditis can permanently damage the heart muscle, possibly causing heart failure.
–
Internal documents contradict Pfizer claim of ‘low incidence of myocarditis’
–
An internal Pfizer document leaked to Project Veritas on Thursday, updated Feb. 11, 2022, and authored by eight scientists in Pfizer’s Drug Safety Research & Development division, indicates that the drugmaker was aware of a connection between mRNA COVID-19 vaccines and higher incidence rates of myocarditis within two weeks of vaccination — particularly following the second dose of the primary series.
–
read more.
end